BioSpace: Why China’s biotech sector thrives despite a global recession

UC political scientist comments on the strength of China’s biopharma gains

China’s foray into biotech companies is relatively new in comparison to Western nations, but it’s gaining speed while other nations struggle with economic downturns.

“China has made a huge push since 2010 to develop biotech companies that can compete at the apex of the world economy,” Thomas Moore, Ph.D., associate professor at UC’s School of Public and International Affairs told BioSpace.

In 2015, he says, the Chinese government launched the Made in China 2025 Initiative to develop key industries to the point where, by 2025, it would not have to rely either on imports of finished products or upon global supply chains in which its companies played a subordinate role in collaborating with major foreign companies.

Moore continued. “Beyond meeting China’s own needs, the additional aim was for these companies to become peer competitors of the large corporate behemoths from other countries that dominate global markets.”

According to the article, in 2000, China did not have one company on the Forbes Global 2000 list. In 2021, it had 14. This is good for second place on this list, behind the United States which had 31.

“The entire Chinese biotech infrastructure, including individual biotech companies themselves, have been the beneficiaries of substantial funding and other kinds of policy and regulatory assistance to help them succeed,” said Moore.

Moore, who is also an affiliate associate professor in Asian Studies, teaches undergraduate and graduate courses on globalization, international political economy, U.S.-China relations, and the politics and international relations of East Asia.

Read the article  

Featured photo at top courtesy of the National Cancer Institute. 

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Related Stories

1

CDC issues new guidelines to help manage potential IUD pain

September 18, 2024

Some women have taken to social media with their experiences of pain when having an intrauterine device, or IUD, inserted. Now the Centers for Disease Control issued guidelines to urge health care providers to address the problem. Priya Gursahaney, MD, associate professor in the University of Cincinnati College of Medicine's Department of Obstetrics and Gynecology, recently appeared on Cincinnati Edition on WVXU to discuss the role that IUDs play in reproductive health care.

2

$300K grant awarded to study airborne MRSA in health care...

September 18, 2024

University of Cincinnati researchers are working to minimize health care workers' exposure to infectious diseases. An Ohio Bureau of Workers’ Compensation grant will fund a study on the presence of MRSA in the air in hospital settings.

Debug Query for this